adipose tissue derived mesenchymal stromal cells therapy (Mayo Clinic)

N/A

Report date: 2022/07/14 17:51:09

Base Information

Drug Nameadipose tissue derived mesenchymal stromal cells therapy (Mayo Clinic)
Drug Alias Nameadipose tissue derived mesenchymal stromal cells (A-MSC)adipose tissue derived mesenchymal stromal cellsA-MSCA-MSC
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsRejection of renal transplantationCartilage Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesMayo Clinic
Inactive CompaniesN/A
Active IndicationsRejection of renal transplantationCartilage Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A